Zobrazeno 1 - 10
of 127
pro vyhledávání: '"G, Klouvas"'
Publikováno v:
Forum of Clinical Oncology, Vol 6, Iss 1, Pp 18-26 (2015)
Background: Novel therapeutic approaches and new compounds during the last decade have prolonged survival of breast cancer patients with metastatic disease, resulting in higher incidence of central nervous system (CNS) metastases. Many of these patie
Externí odkaz:
https://doaj.org/article/1b7a86ff06eb4ff5a8206a16421e3888
Autor:
N. Pavlidis, C. Kalofonos, Anna Kalogera-Fountzila, Lida Kostadima, G. Klouvas, George Fountzilas, Georgios Pentheroudakis
Publikováno v:
Lung Cancer. 45:349-355
Introduction: Patients with cavitating squamous lung carcinoma (cSLC) are believed to harbor aggressive, chemoresistant disease with distinct features and fare poorly. We retrospectively analyzed radiologic, histologic, and clinical features of patie
Autor:
A. Pervena, A. Nikolakopoulou, V. Acholos, G. Karapanagiotidis, C. Christodoulou, A. Visvikis, Eleni Galani, D.V. Skarlos, M. E. Falagas, E. Batziou, G. Tsakalos, G. Klouvas
Publikováno v:
Oncology. 76:209-211
Background: The use of bisphosphonates is associated with osteonecrosis of the jaw (ONJ). Antiangiogenic agents are used with increasing frequency and may induce the risk of ONJ, especially when administered concurrently with bisphosphonates. Patient
Autor:
George Fountzilas, Alexandra V. Stavropoulou, Meletios A. Dimopoulos, Gerassimos E. Voutsinas, George Pentheroudakis, Thomas Makatsoris, Florentia Fostira, Dimitrios Pectasides, Eleni Timotheadou, Gerasimos Aravantinos, G. Klouvas, Maroulio Pertesi, Olga Triantafyllidou, Christos Christodoulou, Irene Konstantopoulou, Vassilis Karydakis, Christos Papadimitriou, Drakoulis Yannoukakos, Aristotelis Bamias, Marianthi Tsitlaidou
Publikováno v:
PLoS ONE, Vol 8, Iss 3, p e58182 (2013)
PLoS ONE
PLoS ONE
Germline mutations in the BRCA1 and BRCA2 genes contribute to approximately 18% of hereditary ovarian cancers conferring an estimated lifetime risk from 15% to 50%. A variable incidence of mutations has been reported for these genes in ovarian cancer
Autor:
Florentia Fostira, George Pentheroudakis, George Fountzilas, Alexandra V. Stavropoulou, Gerassimos E. Voutsinas, Meletios A. Dimopoulos, Vassilis Karydakis, Thomas Makatsoris, Irene Konstantopoulou, Dimitrios Pectasides, Eleni Timotheadou, Olga Triantafyllidou, Drakoulis Yannoukakos, Christos H. Papadimitriou, Gerasimos Aravantinos, Maroulio Pertesi, Aristotelis Bamias, Marianthi Tsitlaidou, Christos Christodoulou, G. Klouvas
Publikováno v:
PLoS ONE, Vol 8, Iss 4 (2013)
PLoS ONE
PLoS ONE
There was an error in the funding statement. The correct funding information is: This research has been co-financed by the European Union (European Social Fund – ESF) and Greek national funds through the Operational Program "Education and Lifelong
Autor:
D. Anastasopoulos, G. Klouvas, Christos Christodoulou, I. Detsi, A. Visvikis, G. Tsiakalos, S. Mellou, D.V. Skarlos, A. Papadimitriou, A. Pateli
Publikováno v:
Anti-Cancer Drugs. 15:997-999
We report Guillain-Barre syndrome (GBS), developed in a patient with metastatic colon cancer, receiving oxaliplatin-based chemotherapy. The 53-year-old patient was treated with first-line chemotherapy consisting of oxaliplatin 45 mg/m2, 5-fluorouraci
Autor:
Alexandra Papoudou-Bai, Eleni Timotheadou, Konstantine T. Kalogeras, Helena Linardou, Angelos Koutras, George Pentheroudakis, Ralph M. Wirtz, Paris Kosmidis, G. Klouvas, Gerasimos Aravantinos, Flora Zagouri, Elke Veltrup, Vasilios Karavasilis, Zoi Alexopoulou, Maria Skondra, George Fountzilas, Meletios A. Dimopoulos, Pavlos Papakostas, Maria Sotiropoulou, Helen Gogas
Publikováno v:
Journal of Clinical Oncology. 34:e23244-e23244
e23244Background: Prevention of bone metastases is a major issue for breast cancer patients, as it would improve quality of life in a population where long survival with metastatic disease is antic...
Autor:
Christos Papandreou, Dimitrios Pectasides, Dimitrios Bafaloukos, Konstantinos N. Syrigos, George Fountzilas, Anastasia G Eleftheraki, G. Klouvas, George Pentheroudakis, Ioannis Xanthakis, Pavlos Papakostas, Thomas Makatsoris, Ioannis Varthalitis, Epaminondas Samantas, Theofanis Economopoulos, Joseph Sgouros, Konstantine T. Kalogeras, George Papaxoinis, Eleni Timotheadou, Nikitas Nikitas, Angelos Koutras
Publikováno v:
BMC Cancer, Vol 12, Iss 1, p 271 (2012)
BMC Cancer
BMC Cancer
Background The aim was to compare two standard chemotherapy regimens combined with bevacizumab as first-line treatment in patients with metastatic colorectal cancer. Methods Patients previously untreated for metastatic disease were randomized in: gro
Publikováno v:
Journal of Chemotherapy. 6:417-422
The main purpose of this trial was to investigate the activity of a less toxic regimen in patients with advanced gastric carcinoma regarding response rate and survival. We report on a pilot study of 20 patients treated with the combination of 5-fluor
Autor:
D.V. Skarlos, E. Samantas, P. Kosmidis, G. Fountzilas, M. Angelidou, P.h. Palamidas, N. Mylonakis, A. Provata, E. Papadakis, G. Klouvas, D. Theocharis, E. Panousaki, E. Boleti, G. Sphakianoudis, N. Pavlidis
Publikováno v:
Annals of Oncology. 5:601-607
Summary Purpose To compare the efficacy and toxicity of etoposide and cisplatin (EP) with etoposide and carboplatin (EC) in combination with irradiation in small-cell lung cancer (SCLC). Methods Previously untreated patients (pts) with SCLC and measu